Ed Silverman is a senior writer and Pharmalot columnist at STAT, and has covered the pharmaceutical industry for three decades. Prior to joining STAT at its founding in 2015, he worked at The Wall Street Journal, The Star-Ledger of New Jersey, and New York Newsday, among other publications. He won the Gerald Loeb Award for business journalism commentary in 2018 for his Pharmalot View columns. Along with several former Wall Street Journal colleagues, Ed was a Pulitzer Prize finalist in explanatory journalism in 2016 for a series of stories on prescription drug pricing. He earned an accounting degree from Binghamton University and a master’s in journalism from New York University.
Journalistic ethics: Ed adheres to the standards outlined in the STAT ethics policy. STAT is committed to truth, accuracy, impartiality, and transparency in our reporting.
